Macroeconomic Dynamics in Pakistan: A VAR Model Analysis of GDP, Inflation, Imports, Exports, and Interest Rates
Socioeconomic Analytics · 2025 · 3 (1) · 50-73
DOI: 10.29327/2565368.3.1-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Socioeconomic Analytics, 2025. Verfasst von Waseem Khoso und 1 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This research explores dynamic relationships between Pakistan's key macroeconomic variables - GDP, inflation, interest rates, imports, and exports - using a Vector Autoregression (VAR) approach to fill significant gaps in understanding Pakistan's distinct economic dynamics. With high-frequency time-series data (1990-2024) from reliable sources such as the State Bank of Pakistan and World Development Indicators, we apply a robust econometric strategy involving Augmented Dickey-Fuller tests for stationarity, Granger causality, Impulse Response Functions, and Forecast Error Variance Decomposition. The findings are three: first, monetary policy indicators (interest rates and inflation) are found to be leading determinants of economic variability, with interest rates showing strong Granger-causal effects on GDP (p
Zitieren
APA
Khoso, W., & Doudpoto, M. R. (2025). Macroeconomic Dynamics in Pakistan: A VAR Model Analysis of GDP, Inflation, Imports, Exports, and Interest Rates. Socioeconomic Analytics, 3(1), 50-73. https://doi.org/10.29327/2565368.3.1-2
Vancouver
Khoso W, Doudpoto MR. Macroeconomic Dynamics in Pakistan: A VAR Model Analysis of GDP, Inflation, Imports, Exports, and Interest Rates. Socioeconomic Analytics. 2025;3(1):50-73. doi:10.29327/2565368.3.1-2
BibTeX
@article{Khoso2025,
author = {Khoso, Waseem and Doudpoto, Muhammad Rafique},
title = {Macroeconomic Dynamics in Pakistan: A VAR Model Analysis of GDP, Inflation, Imports, Exports, and Interest Rates},
journal = {Socioeconomic Analytics},
year = {2025},
volume = {3},
number = {1},
pages = {50--73},
doi = {10.29327/2565368.3.1-2}
}
EUVIMED